Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05083728 · ClinicalTrials.gov registry record

S-32 PG 242 Short Stem

A clinical trial of Osteoporosis, sponsored by St. Louis Joint Replacement Institute.

Completed
Registry status
45
Enrollment target
1
Study location

NCT05083728: Completed study of Osteoporosis, sponsored by St. Louis Joint Replacement Institute.

NCT05083728 is a study of Osteoporosis that has completed, run by St. Louis Joint Replacement Institute. The registered enrollment target is 45 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05083728, a study of Osteoporosis, has completed, sponsored by St. Louis Joint Replacement Institute.

COMPLETED
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

The data of calibrated CT-scans will be used for the Finite Element Analysis (FEA) analysis for SMR Short Stem in identified hospitals in EU and US as developers of the project and for further research, upon subject acceptance. In particular, the Quantitative Computer Tomography (QTC)/Finite Element Analysis (FEA) model of the assembly consisting of the shoulder and the orthopaedic implant allows detailed analyses including: * assessment of micromotion at the bone-implant interface, to predict osseointegration; * comparison of strains/stresses between the intact bone tissue and the bone with the implant in order to predict the stress shielding phenomenon.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST CT

Study Locations (1)

Missouri

  • SSM Health- DePaul - Bridgeton

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-11-01
Est. Completion 2023-07-26

What the Registry Record Tells You About NCT05083728

The ClinicalTrials.gov registry entry for NCT05083728 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (97% lower). The listed sponsor is St. Louis Joint Replacement Institute, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which CT is the first listed.

NCT05083728 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05083728 about?

NCT05083728 is a clinical study titled "S-32 PG 242 Short Stem". The data of calibrated CT-scans will be used for the Finite Element Analysis (FEA) analysis for SMR Short Stem in identified hospitals in EU and US as developers of the project and for further research, upon subject acceptance. In particular, the Quantitative Computer Tomography (QTC)/Finite Elemen...

What is the current status of trial NCT05083728?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2021-11-01. Estimated completion is 2023-07-26.

What conditions does trial NCT05083728 study?

This clinical trial studies the following conditions: Osteoporosis.

What interventions are being tested in trial NCT05083728?

The interventions under investigation include: CT (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05083728?

This trial is sponsored by St. Louis Joint Replacement Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05083728 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.